TP53 and RPA3 gene variations were associated with risk of glioma in a Chinese Han population

Cancer Biotherapy and Radiopharmaceuticals

Volumn 28, Issue 3, 2013, Pages 248-253

  Jin, Tianbo ^a   Zhang, Jiayi ^a   Li, Gang ^b   Li, Shanqu ^c   Yang, Bo ^c   Chen, Chao ^a   Cai, Linbo ^d  

^a NORTHWEST UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d Guangdong 999 Brain Hospital   (China)

Author keywords

Case control study; Glioma; RPA3; Single nucleotide polymorphism (SNP); TP53

Indexed keywords

PROTEIN; PROTEIN P53; RPA3 PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; ASTROCYTOMA; CANCER RISK; CANCER SURGERY; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHILD; CHINESE; CONTROLLED STUDY; EPENDYMOMA; FEMALE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC VARIABILITY; GLIOBLASTOMA; GLIOMA; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OLIGODENDROGLIOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR DIAGNOSIS;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; FEMALE; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLIOMA; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUESTIONNAIRES; RISK FACTORS;

EID: 84876154971     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2012.1291     Document Type: Article

References (28)

1. Schwartzbaum JA, Ahlbom A, Lonn S, et al. An international case-control study of interleukin-4Ralpha, interleukin- 13, and cyclooxygenase-2 polymorphisms and glioblastoma risk. Cancer Epidemiol Biomarkers Prev 2007;16:2448
2. Idbaih A, Criniere E, Ligon KL, et al. Array-based genomics in glioma research. Brain Pathol 2010;20:28
3. Liu Y, Shete S, Hosking F, et al. Genetic advances in glioma: Susceptibility genes and networks. Curr Opin Genet Dev 2010;20:239
4. Hartmann C, Mueller W, von Deimling A. Pathology and molecular genetics of oligodendroglial tumors. J Mol Med (Berl) 2004;82:638
5. Reifenberger G, Collins VP. Pathology and molecular genetics of astrocytic gliomas. J Mol Med (Berl) 2004;82:656
6. Bhatia B, Malik A, Fernandez L A, Kenney AM. p27Kip1, a double-edged sword in Shh-mediated medulloblastoma: Tumor accelerator and suppressor. Cell Cycle 2010;9:4307
7. Zhou LQ, Ma Z, Shi XF, et al. Polymorphisms of DNA repair gene XRCC1 and risk of glioma: A case-control study in Southern China. Asian Pac J Cancer Prev 2011;12:2547
8. Li S, Jin T, Zhang J, et al. Polymorphisms of TREH, IL4R and CCDC26 genes associated with risk of glioma. Cancer Epidemiol 2012;36:283-287
9. Rajaraman P, Wang SS, Rothman N, et al. Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev 2007; 16:1655
10. Bethke L, Webb E, Murray A, et al. Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. Hum Mol Genet 2007;17:800
11. Zhou K, Liu Y, Zhang H, et al. XRCC3 haplotypes and risk of gliomas in a Chinese population: A hospital-based casecontrol study. Int J Cancer 2009;124:2948
12. Liu Y, Zhou K, Zhang H, et al. Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma. Hum Mutat 2008;29:381
13. Liu Y, Zhang H, Zhou K, et al. Tagging SNPs in nonhomologous end-joining pathway genes and risk of glioma. Carcinogenesis 2007;28:1906
14. Gabriel S, Ziaugra L, Tabbaa D. SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet 2009;Chapter 2:Unit 2, 12
15. Thomas RK, Baker AC, Debiasi RM, et al. High-throughput oncogene mutation profiling in human cancer. Nat Genet 2007;39:347
16. Adamec C. [Example of the use of the nonparametric test. Test • 2 for comparison of 2 independent examples]. Cesk Zdrav 1964;12:613
17. Bland JM, Altman DG. Statistics notes. The odds ratio. BMJ 2000;320:1468
18. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263
19. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005;15:97
20. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97
21. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med 2008;359:492
22. Jha P, Pathak P, Chosdol K, et al. TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3. Exp Mol Pathol 2011;90:167
23. Gaudet MM, Gammon MD, Bensen JT, et al. Genetic variation of TP53, polycyclic aromatic hydrocarbon-related exposures, and breast cancer risk among women on Long Island, New York. Breast Cancer Res Treat 2008;108:93
24. Wold MS. Replication protein A: A heterotrimeric, singlestranded DNA-binding protein required for eukaryotic DNA metabolism. Annu Rev Biochem 1997;66:61
25. Iftode C, Daniely Y, Borowiec JA. Replication protein A (RPA): The eukaryotic SSB. Crit Rev Biochem Mol Biol 1999;34:141
26. Fanning E, Klimovich V, Nager AR. A dynamic model for replication protein A (RPA) function in DNA processing pathways. Nucleic Acids Res 2006;34:4126
27. Wold MS, Kelly T. Purification and characterization of replication protein A, a cellular protein required for in vitro replication of simian virus 40 DNA. Proc Natl Acad Sci U S A 1988;85:2523
28. Walther AP, Bjerke MP, Wold MS. A novel assay for examining the molecular reactions at the eukaryotic replication fork: Activities of replication protein A required during elongation. Nucleic Acids Res 1999;27:656